Toledo, OH, United States of America

Paul W Erhardt

USPTO Granted Patents = 42 

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 120(Granted Patents)


Location History:

  • Mundelein, IL (US) (1983 - 1986)
  • Long Valley, NJ (US) (1985 - 1996)
  • Sylvania, OH (US) (1995 - 2013)
  • Toledo, OH (US) (2013 - 2024)

Company Filing History:


Years Active: 1983-2025

Loading Chart...
42 patents (USPTO):Explore Patents

Title: Paul W. Erhardt: Innovator in Cancer Treatment and Metabolic Bone Disease Therapies

Introduction

Paul W. Erhardt, a distinguished inventor based in Toledo, OH, has made significant contributions to the field of medical science with an impressive portfolio of 41 patents. His innovative work has focused primarily on developing materials and methods aimed at inducing cancer cell death and treating various bone-related diseases.

Latest Patents

Among his latest patents, Erhardt has developed compounds and compositions useful for inducing cancer cell death via methods such as methuosis and autophagy. These compounds feature a 4-pyridyl group linked through a heterocyclic group to various aryl, heteroaryl, aralkyl, or heteroaryl alkyl structures. Additionally, he has explored peroxisome proliferator-activated receptor (PPAR) compounds, which are aimed at treating bone fractures, osteoporosis, and metabolic bone diseases, as well as inducing osteogenesis and chondrogenesis.

Career Highlights

Erhardt has had a remarkable career in research and development. He has been associated with esteemed institutions such as the University of Toledo, where he has contributed to academic advancements and medical research. He also worked with American Hospital Supply Corporation, further extending his impact on healthcare solutions.

Collaborations

Throughout his career, Paul W. Erhardt has collaborated with notable professionals, including Bruce E. Heck and Dong Hyun Kim. These partnerships have facilitated significant advancements in their respective fields, highlighting Erhardt's ability to work effectively within collaborative research environments.

Conclusion

With a robust patent portfolio and impactful collaborations, Paul W. Erhardt has established himself as a leading figure in innovative cancer treatments and therapies for metabolic bone diseases. His contributions not only demonstrate his expertise but also pave the way for future advancements in medical science, ultimately aiming to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…